Durability of ChAdOx1 nCoV-19 (Covishield<sup>®</sup>) Vaccine Induced Antibody Response in Health Care Workers

Durability of ChAdOx1 nCoV-19 (Covishield<sup>®</sup>) Vaccine Induced Antibody Response in Health Care Workers

(i) Background: ChAdOx1 nCoV-19 (Covishield<sup>®</sup>) vaccine is widely used in India. We studied the Covishield<sup>®</sup> induced antibody response and its durability among health care workers (HCWs) (ii) Method: HCWs received two doses (0.5 mL) four weeks apart. Blood...

Full description

Bibliographic Details
Main Authors: Alka Verma, Amit Goel, Harshita Katiyar, Prachi Tiwari, Mayank, Asari Sana, Dheeraj Khetan, Dharmendra Singh Bhadauria, Ajay Raja, Neelam Khokher, Shalimar, Ratendra Kumar Singh, Amita Aggarwal
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
COVID-19
coronavirus
Covishield
COVID vaccine
Anti-SARS-CoV-2 antibody
neutralising antibody
Online Access:https://www.mdpi.com/2076-393X/11/1/84

Internet

https://www.mdpi.com/2076-393X/11/1/84

Similar Items